RecruitingNCT04322734

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Sponsor

Southwest Autism Research & Resource Center

Enrollment

500 participants

Start Date

Dec 13, 2023

Study Type

OBSERVATIONAL

Conditions

Brain Tumor Epilepsy Autism Spectrum Disorder Psychiatric Disorder Mitochondrial Pathology Mitochondrial Diseases

Summary

The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate. This study is currently recruiting. There is no cost for visits or study-related exams.

Eligibility

Max Age: 18 Years

Inclusion Criteria3

ASD, as defined by either a gold standard measure for ASD diagnosis, the Autism Diagnostic Observation Schedule (ADOS); the Autism Diagnostic Interview-Revised (ADI-R); and/or a comprehensive assessment that is consistent with ASD, in the opinion of the principal investigator. For those the PI believes a prospective diagnosis of ASD is warranted, a formal diagnostic assessment will be scheduled at screening.
years through 17 years 11 months of age
\. 0 years to 17 years 11 months of age

Exclusion Criteria3

History of a significant adverse reaction to a prior blood draw
In females of reproductive age, pregnancy or plans to become pregnant
Any other historical event/information that may, in the opinion of the PI, be a reason to exclude the child from participation.